Patents by Inventor Marc Rutter

Marc Rutter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human Potassium Channel Genes
    Publication number: 20100273256
    Abstract: Methods for isolating K+Hnov genes are provided. The K+Hnov nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as identification of cell type based on expression, and the like.
    Type: Application
    Filed: April 8, 2009
    Publication date: October 28, 2010
    Applicant: ICAGEN, INC.
    Inventors: ANDREW P. MILLER, PING HU, MARK EDWARD CURRAN, MARC RUTTER, JIAN-YING WANG
  • Human potassium channel genes
    Publication number: 20050112663
    Abstract: Methods for isolating K+Hnov genes are provided. The K+Hnov nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as identification of cell type based on expression, and the like.
    Type: Application
    Filed: October 29, 2004
    Publication date: May 26, 2005
    Applicant: Icagen, Inc.
    Inventors: Andrew Miller, Ping Hu, Mark Curran, Marc Rutter, Jian-Yang Wang
  • Human potassium channel genes
    Publication number: 20050112662
    Abstract: Methods for isolating K+Hnov genes are provided. The K+Hnov nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as identification of cell type based on expression, and the like.
    Type: Application
    Filed: October 29, 2004
    Publication date: May 26, 2005
    Applicant: Icagen, Inc.
    Inventors: Andrew Miller, Ping Hu, Mark Curran, Marc Rutter, Wang Jian-Yang
  • Human potassium channel genes
    Publication number: 20030036648
    Abstract: Methods for isolating K+Hnov genes are provided. The K+Hnov nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as identification of cell type based on expression, and the like.
    Type: Application
    Filed: April 11, 2002
    Publication date: February 20, 2003
    Applicant: ICAgen, Inc.
    Inventors: Andrew P. Miller, Ping Hu, Mark Edward Curran, Marc Rutter, Jian-Yang Wang
  • Nucleic acid encoding human potassium channel K+ nov1 protein
    Patent number: 6399761
    Abstract: Methods for isolating K+Hnov genes are provided. The K+Hnov nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as identification of cell type based on expression, and the like.
    Type: Grant
    Filed: June 18, 1999
    Date of Patent: June 4, 2002
    Assignee: ICAgen, Inc.
    Inventors: Andrew P. Miller, Ping Hu, Mark Edward Curran, Marc Rutter, Wang Jiang-Yang
  • RAQ genes and their uses
    Patent number: 6383792
    Abstract: The invention features polynucleotides encoding novel GTP-binding polypeptides, hereinafter referred to as RAQ polypeptides; expression vectors comprising a RAQ polynucleotide of the invention; isolated cells comprising a RAQ-encoding vector; a transgenic non-human animal comprising an alteration in a RAQ gene; and the use of RAQ polynucleotides in detecting in an individual the presence of a genetic polymorphism of a RAQ gene. The invention further features novel RAQ polypeptides; monoclonal antibodies specific for RAQ polypeptides; and a method for making RAQ polypeptides.
    Type: Grant
    Filed: December 3, 1999
    Date of Patent: May 7, 2002
    Assignee: AxyS Pharmaceuticals, Inc.
    Inventors: Maxine J. Allen, Marc Rutter, Alan J. Buckler
  • RAQ genes and their uses
    Patent number: 6017710
    Abstract: The invention features polynucleotides encoding novel GTP-binding polypeptides, hereinafter referred to as RAQ polypeptides; expression vectors comprising a RAQ polynucleotide of the invention; isolated cells comprising a RAQ-encoding vector; a transgenic non-human animal comprising an alteration in a RAQ gene; and the use of RAQ polynucleotides in detecting in an individual the presence of a genetic polymorphism of a RAQ gene. The invention further features novel RAQ polypeptides; monoclonal antibodies specific for RAQ polypeptides; and a method for making RAQ polypeptides.
    Type: Grant
    Filed: May 13, 1998
    Date of Patent: January 25, 2000
    Assignee: AxyS Pharmaceuticals, Inc.
    Inventors: Maxine J. Allen, Marc Rutter, Alan J. Buckler